OXYCODONE HYDROCHLORIDE

OXYCODONE HYDROCHLORIDE was reported 217261 times

OXYCODONE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POLYSUBSTANCE ABUSE 400 0.6299
1 DRUG DEPENDENCE 100479 0.6243
2 LEARNING DISABILITY 3069 0.5758
3 VISION ABNORMAL NEONATAL 222 0.5311
4 NEONATAL HYPOACUSIS 126 0.5272
5 PRESBYACUSIS 143 0.4643
6 DRUG WITHDRAWAL SYNDROME 36980 0.4210
7 EMOTIONAL DISTRESS 48599 0.4010
8 DRUG ABUSER 2262 0.3677
9 DRUG DIVERSION 2110 0.3413
10 SELF ESTEEM DECREASED 806 0.3326
11 DRUG WITHDRAWAL SYNDROME NEONATAL 4710 0.3178
12 MULTIPLE DRUG OVERDOSE ACCIDENTAL 142 0.3107
13 DEVELOPMENTAL DELAY 2714 0.3006
14 SUBSTANCE DEPENDENCE 201 0.2987
15 VICTIM OF HOMICIDE 173 0.2973
16 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 155 0.2763
17 DRUG TOLERANCE INCREASED 210 0.2689
18 IMPRISONMENT 443 0.2504
19 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 157 0.2350
20 DEEP VEIN THROMBOSIS POSTOPERATIVE 457 0.2282
21 OVERDOSE 49064 0.2272
22 LUPUS VULGARIS 286 0.2270
23 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 455 0.2194
24 DELUSIONAL DISORDER, UNSPECIFIED TYPE 163 0.2179
25 DETOXIFICATION 73 0.2110
26 C-REACTIVE PROTEIN 187 0.2017
27 SWOLLEN JOINT COUNT INCREASED 629 0.1971
28 X-RAY ABNORMAL 347 0.1939
29 DUODENAL ULCER PERFORATION 1420 0.1908
30 MUSCLE INJURY 1576 0.1900
31 DRUG TOLERANCE 942 0.1860
32 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1322 0.1843
33 FACET JOINT SYNDROME 596 0.1829
34 DISLOCATION OF VERTEBRA 414 0.1813
35 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1175 0.1807
36 RHEUMATIC FEVER 798 0.1788
37 PLEURAL FIBROSIS 180 0.1766
38 SUBSTANCE ABUSE 1417 0.1739
39 COUNTERFEIT PRODUCT ADMINISTERED 225 0.1725
40 PLEURAL THICKENING 117 0.1711
41 DISABILITY 3250 0.1642
42 PRODUCT COUNTERFEIT 281 0.1627
43 FOLLICULITIS 1691 0.1611
44 HELICOBACTER INFECTION 1522 0.1479
45 HOMICIDE 265 0.1437
46 SUBSTANCE USE DISORDER 443 0.1389
47 RETINITIS 240 0.1388
48 DRUG DETOXIFICATION 122 0.1365
49 INADEQUATE ANALGESIA 1155 0.1358
50 BLOOD MAGNESIUM INCREASED 122 0.1353
51 RHEUMATOID FACTOR POSITIVE 781 0.1351
52 PEMPHIGUS 1588 0.1269
53 GUN SHOT WOUND 240 0.1264
54 SPINA BIFIDA 257 0.1233
55 JUDGEMENT IMPAIRED 174 0.1197
56 HAND DEFORMITY 1540 0.1173
57 C-REACTIVE PROTEIN ABNORMAL 735 0.1145
58 MULTIPLE CONGENITAL ABNORMALITIES 164 0.1139
59 PERIPHERAL VENOUS DISEASE 457 0.1118
60 POST-TRAUMATIC STRESS DISORDER 735 0.1096
61 OSTEOSCLEROSIS 156 0.0990
62 DRUG ABUSE 8115 0.0974
63 ENTHESOPATHY 150 0.0958
64 PERICARDITIS 1565 0.0931
65 PAIN 56366 0.0917
66 SYNOVITIS 1638 0.0908
67 PORPHYRIA ACUTE 130 0.0906
68 GRANULOMA SKIN 74 0.0901
69 MULTIPLE DRUG OVERDOSE 432 0.0870
70 BONE CYST 79 0.0842
71 TOXICITY TO VARIOUS AGENTS 14083 0.0834
72 IRRITABLE BOWEL SYNDROME 1778 0.0828
73 GENERAL PHYSICAL CONDITION ABNORMAL 560 0.0825
74 ANTISOCIAL BEHAVIOUR 77 0.0770
75 MENTAL DISORDER 3256 0.0747
76 CONGENITAL ANOMALY 567 0.0732
77 EXPOSURE VIA FATHER 95 0.0728
78 GLOSSODYNIA 1627 0.0726
79 DRUG USE DISORDER 597 0.0709
80 SERONEGATIVE ARTHRITIS 81 0.0707
81 LIP DRY 639 0.0703
82 PHYSICAL ASSAULT 143 0.0684
83 WOUND INFECTION 734 0.0670
84 BURSITIS 804 0.0662
85 CANCER PAIN 168 0.0657
86 JOINT RANGE OF MOTION DECREASED 881 0.0656
87 BREAST CANCER STAGE III 422 0.0651
88 EUPHORIC MOOD 648 0.0632
89 BONE EROSION 223 0.0630
90 ROAD TRAFFIC ACCIDENT 2549 0.0609
91 HYPERCHOLESTEROLAEMIA 587 0.0607
92 WITHDRAWAL SYNDROME 2533 0.0603
93 BREAKTHROUGH PAIN 139 0.0600
94 DEAFNESS NEUROSENSORY 197 0.0598
95 COMPLEX REGIONAL PAIN SYNDROME 88 0.0595
96 MATERNAL EXPOSURE TIMING UNSPECIFIED 223 0.0593
97 IMPAIRED DRIVING ABILITY 667 0.0586
98 IMPAIRED HEALING 1925 0.0586
99 GRIP STRENGTH DECREASED 515 0.0585
100 HEPATITIS C 702 0.0581
101 WOUND 1613 0.0576
102 RESPIRATORY RATE DECREASED 177 0.0563
103 DRUG TOLERANCE DECREASED 158 0.0562
104 ALANINE AMINOTRANSFERASE ABNORMAL 117 0.0554
105 AUTOIMMUNE DISORDER 537 0.0550
106 TENOSYNOVITIS 148 0.0536
107 IMPAIRED WORK ABILITY 1121 0.0524
108 FIBROMYALGIA 1267 0.0521
109 BRAIN INJURY 522 0.0520
110 INTENTIONAL MISUSE 99 0.0518
111 INJURY 3627 0.0515
112 BLOOD PARATHYROID HORMONE DECREASED 76 0.0512
113 NEAR DEATH EXPERIENCE 169 0.0512
114 LIVE BIRTH 422 0.0504
115 BEHAVIOUR DISORDER 270 0.0499
116 ATTENTION DEFICIT HYPERACTIVITY DISORDER 209 0.0496
117 MAJOR DEPRESSION 360 0.0492
118 ACCIDENTAL OVERDOSE 1797 0.0491
119 LIVER INJURY 1205 0.0490
120 ACCIDENTAL DEATH 91 0.0489
121 FOETAL EXPOSURE DURING PREGNANCY 3974 0.0488
122 MIOSIS 392 0.0488
123 TOOTH LOSS 1001 0.0482
124 PUSTULAR PSORIASIS 163 0.0474
125 SYSTEMIC LUPUS ERYTHEMATOSUS 1683 0.0474
126 SPINAL FUSION SURGERY 190 0.0468
127 DRUG SCREEN POSITIVE 367 0.0464
128 ALCOHOL ABUSE 123 0.0459
129 ESSENTIAL HYPERTENSION 84 0.0459
130 CONTRAINDICATED PRODUCT ADMINISTERED 1386 0.0457
131 DEPENDENCE 2502 0.0456
132 BACK INJURY 496 0.0456
133 ALCOHOL POISONING 122 0.0455
134 RESPIRATORY DEPRESSION 549 0.0447
135 PERSONALITY CHANGE 407 0.0438
136 PHYSICAL DISABILITY 189 0.0427
137 EXOSTOSIS 388 0.0424
138 QUALITY OF LIFE DECREASED 569 0.0424
139 DENTAL CARIES 469 0.0424
140 NECK INJURY 122 0.0415
141 UNEVALUABLE EVENT 3122 0.0412
142 EPIGASTRIC DISCOMFORT 161 0.0412
143 EXPOSED BONE IN JAW 89 0.0410
144 LOWER RESPIRATORY TRACT INFECTION 1829 0.0402
145 BREAST CANCER STAGE II 334 0.0401
146 OSTEOLYSIS 82 0.0401
147 INTERVERTEBRAL DISC DEGENERATION 368 0.0397
148 PRODUCT FORMULATION ISSUE 262 0.0397
149 OBESITY 630 0.0395
150 PULMONARY FIBROSIS 757 0.0394
151 HYPOPNOEA 134 0.0386
152 RASH VESICULAR 186 0.0384
153 PRESCRIBED OVERDOSE 742 0.0383
154 BRADYPNOEA 101 0.0374
155 NECK SURGERY 87 0.0373
156 ANXIETY DISORDER 123 0.0368
157 ALCOHOLISM 157 0.0366
158 DELIRIUM 1271 0.0366
159 SCIATICA 577 0.0362
160 SOCIAL AVOIDANT BEHAVIOUR 209 0.0361
161 SUICIDAL BEHAVIOUR 150 0.0360
162 THERAPEUTIC PRODUCT EFFECT DECREASED 1609 0.0359
163 LOWER LIMB FRACTURE 684 0.0356
164 TYPE 2 DIABETES MELLITUS 1191 0.0353
165 STOMATITIS 2142 0.0353
166 DEPRESSION 7974 0.0350
167 RHEUMATOID NODULE 96 0.0348
168 IMPAIRED QUALITY OF LIFE 501 0.0348
169 PERSONALITY DISORDER 91 0.0347
170 BLISTER 1944 0.0346
171 TEMPERATURE REGULATION DISORDER 77 0.0345
172 ULCER HAEMORRHAGE 233 0.0344
173 ARTHROPATHY 1903 0.0342
174 AMNESIA 2207 0.0339
175 PANNICULITIS 82 0.0339
176 MATERNAL EXPOSURE DURING PREGNANCY 2984 0.0334
177 TOOTH INJURY 145 0.0334
178 RADICULOPATHY 88 0.0334
179 ONYCHOMADESIS 138 0.0328
180 RED BLOOD CELL SEDIMENTATION RATE INCREASED 363 0.0328
181 SPINAL OPERATION 403 0.0327
182 BLEPHAROSPASM 203 0.0322
183 WALKING AID USER 212 0.0321
184 NAIL DISORDER 279 0.0319
185 BONE LESION 114 0.0316
186 SPINAL OSTEOARTHRITIS 273 0.0310
187 MENTAL IMPAIRMENT 753 0.0310
188 NIGHT SWEATS 999 0.0310
189 OSTEOARTHRITIS 1312 0.0309
190 GAIT INABILITY 1029 0.0308
191 HYPERAESTHESIA 252 0.0306
192 FINGER DEFORMITY 145 0.0299
193 PRODUCT PRESCRIBING ISSUE 644 0.0295
194 NERVE INJURY 326 0.0293
195 EYE INJURY 89 0.0293
196 METASTASES TO SPINE 98 0.0291
197 PARANOIA 501 0.0290
198 BIPOLAR DISORDER 315 0.0289
199 HIP ARTHROPLASTY 437 0.0285
200 ANXIETY 8077 0.0284
201 ARTERIOSCLEROSIS CORONARY ARTERY 187 0.0282
202 ATELECTASIS 270 0.0279
203 COMPLETED SUICIDE 2328 0.0279
204 OBSESSIVE-COMPULSIVE DISORDER 224 0.0279
205 ILL-DEFINED DISORDER 1692 0.0278
206 FUNCTIONAL GASTROINTESTINAL DISORDER 96 0.0277
207 CRANIOCEREBRAL INJURY 84 0.0277
208 LUMBAR SPINAL STENOSIS 81 0.0277
209 DEATH 23872 0.0277
210 INFUSION RELATED REACTION 1829 0.0276
211 HEPATIC ENZYME INCREASED 1874 0.0275
212 PSORIATIC ARTHROPATHY 1113 0.0274
213 PATHOLOGICAL FRACTURE 139 0.0274
214 REHABILITATION THERAPY 106 0.0273
215 ONYCHOMYCOSIS 120 0.0273
216 JOINT DISLOCATION 289 0.0273
217 INFUSION SITE REACTION 81 0.0271
218 DECREASED INTEREST 159 0.0269
219 GENERAL PHYSICAL HEALTH DETERIORATION 3080 0.0266
220 COMPRESSION FRACTURE 142 0.0265
221 LOSS OF EMPLOYMENT 80 0.0265
222 SLEEP APNOEA SYNDROME 503 0.0263
223 DRUG EFFECT INCREASED 83 0.0262
224 PRODUCT LABEL CONFUSION 153 0.0262
225 CARDIOMEGALY 320 0.0260
226 BACK DISORDER 421 0.0259
227 DISCOMFORT 1566 0.0256
228 RESPIRATORY ARREST 705 0.0255
229 SLEEP DISORDER 1799 0.0255
230 NEPHROGENIC ANAEMIA 118 0.0254
231 PRE-EXISTING CONDITION IMPROVED 158 0.0253
232 GASTROINTESTINAL DISORDER 2267 0.0253
233 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 432 0.0252
234 METABOLIC ENCEPHALOPATHY 75 0.0250
235 LUPUS-LIKE SYNDROME 226 0.0249
236 PSYCHOLOGICAL TRAUMA 214 0.0248
237 SUICIDAL IDEATION 2244 0.0245
238 CEREBRAL DISORDER 180 0.0243
239 KNEE ARTHROPLASTY 510 0.0242
240 MYOSITIS 216 0.0240
241 DIASTOLIC DYSFUNCTION 74 0.0239
242 COMA 1136 0.0238
243 ENDOCARDITIS 122 0.0238
244 PANIC DISORDER 92 0.0237
245 INTERVERTEBRAL DISC DISORDER 101 0.0236
246 SELF-MEDICATION 97 0.0236
247 SUSPECTED SUICIDE 110 0.0234
248 CHRONIC SINUSITIS 88 0.0234
249 ARTERIOSCLEROSIS 220 0.0234
250 FACIAL BONES FRACTURE 84 0.0233
251 HEPATIC CIRRHOSIS 438 0.0233
252 SWELLING 2167 0.0231
253 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1111 0.0231
254 BLOOD CHOLESTEROL INCREASED 1077 0.0231
255 CONFUSIONAL STATE 3722 0.0230
256 SUICIDE ATTEMPT 1390 0.0229
257 SNORING 86 0.0227
258 THINKING ABNORMAL 420 0.0225
259 DRUG INTOLERANCE 2171 0.0225
260 JOINT SWELLING 2706 0.0224
261 OSTEOPENIA 340 0.0224
262 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 92 0.0221
263 PRESCRIBED UNDERDOSE 440 0.0220
264 GENERAL SYMPTOM 165 0.0220
265 EAR PAIN 426 0.0219
266 OEDEMA 1178 0.0217
267 CARDIAC DISORDER 2031 0.0217
268 ALCOHOL USE 80 0.0217
269 MULTIPLE MYELOMA 101 0.0217
270 FAILURE TO THRIVE 112 0.0216
271 UNRESPONSIVE TO STIMULI 555 0.0215
272 CONTUSION 2069 0.0215
273 INCOHERENT 139 0.0215
274 SEXUAL DYSFUNCTION 251 0.0214
275 SPINAL COLUMN STENOSIS 101 0.0214
276 SCOLIOSIS 132 0.0213
277 HEART DISEASE CONGENITAL 75 0.0212
278 LIVER DISORDER 938 0.0211
279 INTERVERTEBRAL DISC PROTRUSION 455 0.0208
280 HYPERCALCAEMIA 257 0.0208
281 OSTEOMYELITIS 376 0.0207
282 EXPOSURE DURING PREGNANCY 1288 0.0207
283 TOOTH DISORDER 457 0.0205
284 DECUBITUS ULCER 167 0.0205
285 TONGUE DISORDER 148 0.0204
286 WHEEZING 1211 0.0204
287 SPINAL STENOSIS 84 0.0203
288 SINUSITIS 2071 0.0202
289 BLOOD TESTOSTERONE DECREASED 138 0.0202
290 LUNG DISORDER 982 0.0200
291 MOBILITY DECREASED 1439 0.0200
292 ANGER 674 0.0199
293 LEG AMPUTATION 82 0.0199
294 COELIAC DISEASE 195 0.0199
295 MOOD SWINGS 633 0.0198
296 FOOT DEFORMITY 219 0.0197
297 CARDIO-RESPIRATORY ARREST 821 0.0196
298 ASPIRATION 215 0.0196
299 CARDIAC MURMUR 169 0.0195
300 FAECALOMA 107 0.0195
301 AFFECTIVE DISORDER 153 0.0194
302 CACHEXIA 100 0.0194
303 MALNUTRITION 217 0.0194
304 MUSCULOSKELETAL PAIN 1014 0.0193
305 SEDATION 505 0.0193
306 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 118 0.0191
307 BONE DISORDER 348 0.0191
308 FEELING OF DESPAIR 89 0.0191
309 MENTAL STATUS CHANGES 525 0.0189
310 SPINAL COMPRESSION FRACTURE 156 0.0188
311 CYST 234 0.0188
312 EMPHYSEMA 190 0.0188
313 MEDICATION ERROR 1045 0.0188
314 DIVERTICULUM 132 0.0186
315 RIB FRACTURE 379 0.0184
316 BEDRIDDEN 240 0.0182
317 RHEUMATOID ARTHRITIS 2064 0.0182
318 INFECTION 2631 0.0182
319 PULMONARY CONGESTION 239 0.0181
320 TRICUSPID VALVE INCOMPETENCE 144 0.0181
321 SKIN NECROSIS 93 0.0179
322 ILEUS PARALYTIC 80 0.0179
323 CONSTIPATION 3884 0.0178
324 LEFT VENTRICULAR HYPERTROPHY 76 0.0177
325 METASTASES TO BONE 291 0.0177
326 C-REACTIVE PROTEIN INCREASED 631 0.0173
327 GINGIVAL PAIN 138 0.0173
328 BLOOD ALBUMIN DECREASED 137 0.0173
329 FORMICATION 120 0.0172
330 INTENTIONAL PRODUCT USE ISSUE 1484 0.0169
331 DEPRESSED LEVEL OF CONSCIOUSNESS 668 0.0169
332 MUSCULOSKELETAL STIFFNESS 1476 0.0168
333 MUSCLE SPASTICITY 207 0.0168
334 RENAL CELL CARCINOMA 82 0.0167
335 PERIPHERAL SWELLING 2572 0.0167
336 DISTURBANCE IN ATTENTION 900 0.0167
337 INFLAMMATION 860 0.0166
338 LUNG INFILTRATION 147 0.0166
339 THERAPY NON-RESPONDER 748 0.0166
340 DRY MOUTH 1346 0.0166
341 ACCIDENT 198 0.0166
342 NON-SMALL CELL LUNG CANCER 79 0.0165
343 ABDOMINAL DISCOMFORT 2759 0.0164
344 PSYCHIATRIC SYMPTOM 121 0.0164
345 DEFORMITY 153 0.0164
346 ULCER 260 0.0163
347 JOINT EFFUSION 112 0.0162
348 JOINT INJURY 345 0.0161
349 PREGNANCY 321 0.0160
350 LUMBAR VERTEBRAL FRACTURE 73 0.0159
351 THERMAL BURN 113 0.0159
352 TASTE DISORDER 323 0.0159
353 CONCUSSION 123 0.0159
354 HYPERHIDROSIS 2041 0.0158
355 FAECAL INCONTINENCE 76 0.0158
356 PNEUMONIA ASPIRATION 395 0.0158
357 APNOEA 123 0.0158
358 PANIC ATTACK 575 0.0158
359 TOOTHACHE 285 0.0157
360 SPINAL DISORDER 149 0.0157
361 COLD SWEAT 277 0.0157
362 BLOOD POTASSIUM INCREASED 255 0.0157
363 OSTEONECROSIS OF JAW 387 0.0156
364 TOOTH ABSCESS 159 0.0156
365 MYOCLONUS 186 0.0156
366 GINGIVITIS 84 0.0156
367 MEDICATION RESIDUE PRESENT 74 0.0155
368 KNEE OPERATION 152 0.0154
369 SOMNOLENCE 3106 0.0154
370 HYPERLIPIDAEMIA 184 0.0154
371 SOMNAMBULISM 101 0.0154
372 ANOREXIA 198 0.0153
373 INSOMNIA 4086 0.0153
374 RESPIRATORY DISORDER 458 0.0153
375 MIGRAINE 1458 0.0153
376 TOOTH FRACTURE 168 0.0152
377 PERIPHERAL VASCULAR DISORDER 78 0.0151
378 AGGRESSION 755 0.0151
379 OSTEOPOROSIS 620 0.0151
380 SURGERY 883 0.0150
381 SPINAL FRACTURE 301 0.0150
382 HYPOXIA 528 0.0150
383 TENDERNESS 156 0.0150
384 HYPERSOMNIA 429 0.0149
385 TREATMENT FAILURE 1239 0.0149
386 FLANK PAIN 140 0.0149
387 SINUS TACHYCARDIA 212 0.0149
388 BODY TEMPERATURE INCREASED 304 0.0149
389 HIATUS HERNIA 192 0.0148
390 INTENTIONAL DRUG MISUSE 308 0.0147
391 NIGHTMARE 509 0.0147
392 MUSCULOSKELETAL CHEST PAIN 227 0.0147
393 DYSARTHRIA 552 0.0146
394 LIVER FUNCTION TEST INCREASED 313 0.0146
395 ABNORMAL BEHAVIOUR 576 0.0145
396 RESTLESS LEGS SYNDROME 264 0.0145
397 IRON DEFICIENCY ANAEMIA 134 0.0145
398 FEELING OF BODY TEMPERATURE CHANGE 85 0.0145
399 HYSTERECTOMY 125 0.0144
400 URINARY RETENTION 480 0.0144
401 PRODUCT SIZE ISSUE 77 0.0143
402 LOSS OF CONSCIOUSNESS 1830 0.0143
403 HYPOALBUMINAEMIA 111 0.0143
404 NEURALGIA 347 0.0143
405 RHINITIS 115 0.0142
406 DYSPEPSIA 1403 0.0142
407 TOOTH EXTRACTION 177 0.0142
408 HALLUCINATION 1070 0.0142
409 LARGE INTESTINE PERFORATION 98 0.0141
410 DELUSION 218 0.0140
411 MEMORY IMPAIRMENT 1925 0.0140
412 DECREASED APPETITE 3250 0.0140
413 DISSEMINATED INTRAVASCULAR COAGULATION 197 0.0140
414 COGNITIVE DISORDER 653 0.0140
415 ILLNESS 1439 0.0140
416 DRUG TOXICITY 190 0.0139
417 ASPHYXIA 113 0.0138
418 SENSORY LOSS 111 0.0138
419 BLOOD PRESSURE SYSTOLIC INCREASED 266 0.0136
420 SMALL INTESTINAL OBSTRUCTION 167 0.0136
421 BRUXISM 73 0.0135
422 ANKLE FRACTURE 209 0.0135
423 HYPOVOLAEMIA 79 0.0135
424 MALIGNANT NEOPLASM PROGRESSION 1381 0.0135
425 RENAL CYST 107 0.0135
426 ILEUS 167 0.0134
427 HYPOAESTHESIA 2007 0.0134
428 OEDEMA PERIPHERAL 1634 0.0134
429 WEIGHT INCREASED 2992 0.0133
430 LIMB INJURY 362 0.0133
431 RENAL FAILURE CHRONIC 102 0.0133
432 SKIN LESION 363 0.0132
433 ACUTE RESPIRATORY FAILURE 254 0.0132
434 ADVERSE REACTION 175 0.0132
435 LYMPHOEDEMA 91 0.0131
436 SKIN ULCER 340 0.0131
437 PNEUMOTHORAX 208 0.0131
438 ERECTILE DYSFUNCTION 336 0.0131
439 DRUG EFFECT DECREASED 701 0.0130
440 GASTROOESOPHAGEAL REFLUX DISEASE 1045 0.0130
441 NECK PAIN 725 0.0130
442 PELVIC FRACTURE 101 0.0130
443 INCONTINENCE 137 0.0129
444 LETHARGY 744 0.0129
445 NASOPHARYNGITIS 2382 0.0129
446 PAROSMIA 97 0.0128
447 ROTATOR CUFF SYNDROME 165 0.0128
448 ALTERED STATE OF CONSCIOUSNESS 277 0.0128
449 HEPATIC FAILURE 383 0.0127
450 JOINT STIFFNESS 331 0.0126
451 VOMITING 5902 0.0125
452 BACK PAIN 2911 0.0125
453 WEIGHT FLUCTUATION 130 0.0124
454 END STAGE RENAL DISEASE 226 0.0124
455 BLOOD CALCIUM DECREASED 139 0.0123
456 HYPERTENSION 2613 0.0123
457 PARALYSIS 174 0.0121
458 HAEMORRHOIDS 237 0.0121
459 INTERSTITIAL LUNG DISEASE 588 0.0121
460 ACTIVITIES OF DAILY LIVING IMPAIRED 240 0.0121
461 SICKLE CELL ANAEMIA WITH CRISIS 191 0.0121
462 CARDIAC ARREST 1000 0.0121
463 PRODUCT ADMINISTRATION INTERRUPTED 95 0.0121
464 HEAD INJURY 381 0.0120
465 ADRENAL INSUFFICIENCY 146 0.0120
466 HAND FRACTURE 85 0.0120
467 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 626 0.0120
468 HYPERSENSITIVITY 2223 0.0120
469 BRAIN OEDEMA 151 0.0119
470 ECONOMIC PROBLEM 181 0.0119
471 HEPATIC STEATOSIS 222 0.0119
472 RESPIRATION ABNORMAL 82 0.0119
473 ORAL PAIN 266 0.0119
474 TOOTH INFECTION 156 0.0118
475 FOOT FRACTURE 224 0.0118
476 DISORIENTATION 468 0.0118
477 SCAR 202 0.0118
478 SPINAL PAIN 138 0.0118
479 CHOLANGITIS 73 0.0118
480 CELLULITIS 592 0.0117
481 BRONCHIECTASIS 79 0.0117
482 PROCTALGIA 75 0.0117
483 INTENTIONAL PRODUCT MISUSE 1020 0.0116
484 PULMONARY MASS 173 0.0116
485 RESPIRATORY RATE INCREASED 103 0.0116
486 ABDOMINAL PAIN UPPER 2383 0.0116
487 DYSURIA 426 0.0116
488 HYPOCALCAEMIA 219 0.0116
489 HOSPITALISATION 1777 0.0116
490 ENCEPHALOPATHY 284 0.0116
491 ECCHYMOSIS 79 0.0115
492 TERMINAL STATE 77 0.0115
493 HYDRONEPHROSIS 86 0.0115
494 PULMONARY OEDEMA 513 0.0114
495 ANHEDONIA 301 0.0114
496 METASTASES TO LUNG 132 0.0114
497 CARPAL TUNNEL SYNDROME 160 0.0114
498 DEEP VEIN THROMBOSIS 740 0.0114
499 APATHY 166 0.0114
500 ANAL INCONTINENCE 102 0.0113
501 MUSCLE STRAIN 98 0.0113
502 POST PROCEDURAL INFECTION 92 0.0113
503 HYPOKALAEMIA 522 0.0113
504 UPPER RESPIRATORY TRACT INFECTION 522 0.0113
505 INTESTINAL OBSTRUCTION 425 0.0113
506 FEEDING DISORDER 228 0.0112
507 WEIGHT DECREASED 3136 0.0112
508 LOSS OF LIBIDO 101 0.0112
509 ORAL DISORDER 82 0.0112
510 POISONING DELIBERATE 106 0.0112
511 MASS 156 0.0112
512 IRRITABILITY 670 0.0111
513 BLOOD PRESSURE DIASTOLIC DECREASED 82 0.0111
514 FREQUENT BOWEL MOVEMENTS 300 0.0111
515 ELECTROLYTE IMBALANCE 129 0.0111
516 ALOPECIA 2180 0.0111
517 HYPOPHOSPHATAEMIA 82 0.0111
518 CHEST PAIN 2052 0.0111
519 MITRAL VALVE INCOMPETENCE 125 0.0110
520 EATING DISORDER 235 0.0110
521 IMPAIRED GASTRIC EMPTYING 150 0.0110
522 LOCALISED INFECTION 266 0.0110
523 HEPATOMEGALY 108 0.0110
524 TENDONITIS 170 0.0110
525 HICCUPS 90 0.0110
526 PYREXIA 3790 0.0109
527 SEROTONIN SYNDROME 209 0.0109
528 ORAL CANDIDIASIS 143 0.0108
529 CHOLECYSTECTOMY 124 0.0108
530 FLUID RETENTION 552 0.0108
531 HAEMATOCRIT DECREASED 215 0.0108
532 SEPSIS 1208 0.0108
533 BLOOD ALKALINE PHOSPHATASE INCREASED 268 0.0108
534 CANDIDA INFECTION 182 0.0108
535 NERVE COMPRESSION 99 0.0107
536 PLASMA CELL MYELOMA 418 0.0107
537 PNEUMONIA 3466 0.0107
538 INTENTIONAL SELF-INJURY 216 0.0107
539 CYANOSIS 168 0.0107
540 RESPIRATORY FAILURE 779 0.0107
541 PNEUMONIA BACTERIAL 98 0.0107
542 PLEURAL EFFUSION 649 0.0107
543 MUSCLE ATROPHY 135 0.0106
544 ASPARTATE AMINOTRANSFERASE INCREASED 565 0.0106
545 PAIN IN JAW 301 0.0106
546 FOOD ALLERGY 82 0.0106
547 MUSCLE SPASMS 1947 0.0106
548 IMMUNODEFICIENCY 158 0.0106
549 GROIN PAIN 93 0.0106
550 METASTASES TO LIVER 186 0.0106
551 UPPER LIMB FRACTURE 210 0.0105
552 EAR INFECTION 280 0.0105
553 AFFECT LABILITY 101 0.0105
554 DEHYDRATION 1398 0.0105
555 RESPIRATORY DISTRESS 289 0.0105
556 METASTASES TO CENTRAL NERVOUS SYSTEM 135 0.0105
557 EMOTIONAL DISORDER 322 0.0104
558 HALLUCINATION, VISUAL 220 0.0104
559 FACIAL PAIN 93 0.0104
560 PULMONARY THROMBOSIS 113 0.0104
561 RENAL FAILURE 1376 0.0104
562 NEUTROPENIC SEPSIS 74 0.0104
563 NEUROPATHY PERIPHERAL 985 0.0103
564 RENAL DISORDER 482 0.0103
565 STAPHYLOCOCCAL INFECTION 341 0.0103
566 PULMONARY EMBOLISM 978 0.0103
567 HEPATIC ENCEPHALOPATHY 96 0.0103
568 CLOSTRIDIUM DIFFICILE COLITIS 109 0.0103
569 ARTHRITIS 806 0.0102
570 CARDIAC OPERATION 88 0.0102
571 ARTHRALGIA 4255 0.0102
572 ASCITES 300 0.0102
573 WRIST FRACTURE 122 0.0102
574 RECTAL HAEMORRHAGE 437 0.0102
575 AGITATION 746 0.0101
576 FALL 3370 0.0101
577 HEPATITIS 259 0.0101
578 DIVERTICULITIS 280 0.0101
579 BONE PAIN 590 0.0101
580 INTESTINAL PERFORATION 113 0.0101
581 HYPOPHAGIA 257 0.0100
582 SEASONAL ALLERGY 142 0.0100
583 NAUSEA 7929 0.0100
584 BASAL CELL CARCINOMA 156 0.0100
585 CHRONIC KIDNEY DISEASE 759 0.0100
586 ADVERSE DRUG REACTION 895 0.0100
587 TREMOR 1652 0.0099
588 MUSCLE TWITCHING 229 0.0099
589 FEAR 267 0.0099
590 TUBULOINTERSTITIAL NEPHRITIS 186 0.0099
591 DRUG-INDUCED LIVER INJURY 311 0.0099
592 GAIT DISTURBANCE 1894 0.0099
593 LACERATION 93 0.0099
594 PSYCHOTIC DISORDER 292 0.0099
595 LIGAMENT SPRAIN 97 0.0098
596 URTICARIA 1635 0.0097
597 BLOOD CREATININE INCREASED 637 0.0097
598 RESTLESSNESS 357 0.0097
599 MUSCULAR WEAKNESS 1105 0.0097
600 URINARY INCONTINENCE 288 0.0097
601 PAIN IN EXTREMITY 2860 0.0097
602 OXYGEN SATURATION DECREASED 545 0.0097
603 CARDIOMYOPATHY 143 0.0097
604 MUSCULOSKELETAL DISCOMFORT 166 0.0096
605 HOSPICE CARE 95 0.0096
606 ABDOMINAL PAIN 2230 0.0096
607 BODY TEMPERATURE DECREASED 94 0.0095
608 NERVOUSNESS 498 0.0095
609 HEPATIC FUNCTION ABNORMAL 355 0.0095
610 BLOOD MAGNESIUM DECREASED 82 0.0095
611 GASTRIC DISORDER 325 0.0095
612 BLOOD SODIUM DECREASED 178 0.0094
613 VITAMIN D DEFICIENCY 92 0.0094
614 BRONCHITIS 697 0.0094
615 BLOOD POTASSIUM DECREASED 283 0.0094
616 CRYING 342 0.0094
617 WHITE BLOOD CELL COUNT INCREASED 361 0.0094
618 BLOOD LACTATE DEHYDROGENASE INCREASED 149 0.0094
619 ASTHMA 1062 0.0094
620 RENAL FAILURE ACUTE 398 0.0094
621 RENAL TUBULAR NECROSIS 92 0.0094
622 NEUTROPHIL COUNT DECREASED 382 0.0094
623 HIP FRACTURE 301 0.0093
624 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 218 0.0093
625 ASTHENIA 3516 0.0093
626 MOOD ALTERED 255 0.0093
627 HEPATIC CYTOLYSIS 119 0.0093
628 MOTOR DYSFUNCTION 95 0.0093
629 GASTRITIS 244 0.0093
630 GASTRIC ULCER 176 0.0093
631 NEPHROLITHIASIS 424 0.0092
632 LEUKOCYTOSIS 167 0.0092
633 SPLENOMEGALY 108 0.0092
634 GENERALISED OEDEMA 114 0.0092
635 ALANINE AMINOTRANSFERASE INCREASED 565 0.0092
636 MYDRIASIS 118 0.0092
637 BLOOD UREA INCREASED 154 0.0092
638 IMMUNE SYSTEM DISORDER 121 0.0092
639 HEART RATE DECREASED 322 0.0092
640 BODY HEIGHT DECREASED 98 0.0092
641 HAEMATEMESIS 232 0.0091
642 OBSTRUCTIVE AIRWAYS DISORDER 101 0.0091
643 INFUSION SITE PAIN 117 0.0091
644 NEOPLASM PROGRESSION 315 0.0090
645 HYPOMAGNESAEMIA 126 0.0090
646 URINE OUTPUT DECREASED 79 0.0090
647 TINNITUS 415 0.0090
648 CHILLS 1058 0.0090
649 SKIN LACERATION 98 0.0090
650 LYMPHOCYTE COUNT DECREASED 159 0.0090
651 FRACTURE 170 0.0090
652 DYSPNOEA 5083 0.0090
653 HYPERKALAEMIA 314 0.0089
654 SENSORY DISTURBANCE 143 0.0089
655 EPILEPSY 272 0.0089
656 UROSEPSIS 82 0.0089
657 FEELING JITTERY 169 0.0089
658 PULMONARY HYPERTENSION 184 0.0088
659 NERVOUS SYSTEM DISORDER 274 0.0088
660 RASH 3803 0.0087
661 FATIGUE 6785 0.0087
662 ABSCESS 139 0.0087
663 PHARMACEUTICAL PRODUCT COMPLAINT 225 0.0087
664 BREAST CANCER METASTATIC 93 0.0087
665 NOCTURIA 105 0.0086
666 PRODUCT PRESCRIBING ERROR 206 0.0086
667 SKIN INFECTION 97 0.0086
668 TUMOUR LYSIS SYNDROME 76 0.0086
669 GALLBLADDER DISORDER 154 0.0086
670 SEIZURE 996 0.0086
671 FULL BLOOD COUNT DECREASED 173 0.0086
672 DYSSTASIA 250 0.0086
673 ACUTE KIDNEY INJURY 1310 0.0086
674 GASTROINTESTINAL PAIN 94 0.0085
675 COORDINATION ABNORMAL 119 0.0085
676 CORONARY ARTERY DISEASE 257 0.0085
677 FEBRILE NEUTROPENIA 563 0.0085
678 DYSPNOEA EXERTIONAL 319 0.0085
679 MALAISE 3702 0.0084
680 RED BLOOD CELL COUNT DECREASED 241 0.0084
681 BACTERAEMIA 100 0.0084
682 ACUTE RESPIRATORY DISTRESS SYNDROME 149 0.0084
683 OESOPHAGITIS 92 0.0084
684 BONE MARROW FAILURE 171 0.0084
685 SPEECH DISORDER 440 0.0084
686 PANCYTOPENIA 468 0.0084
687 ANAEMIA 1597 0.0084
688 PARAESTHESIA 1316 0.0084
689 BLADDER DISORDER 83 0.0084
690 CONDITION AGGRAVATED 2535 0.0083
691 THROMBOCYTOPENIA 928 0.0083
692 HYPONATRAEMIA 467 0.0083
693 POST PROCEDURAL COMPLICATION 159 0.0083
694 TACHYCARDIA 725 0.0082
695 DIARRHOEA 5265 0.0081
696 HYPOTHYROIDISM 260 0.0081
697 POOR QUALITY SLEEP 175 0.0081
698 MULTIPLE ORGAN DYSFUNCTION SYNDROME 230 0.0081
699 PLATELET COUNT DECREASED 865 0.0081
700 RETCHING 173 0.0081
701 ABDOMINAL DISTENSION 847 0.0081
702 APHASIA 245 0.0081
703 INTENTIONAL OVERDOSE 518 0.0081
704 THROMBOSIS 647 0.0080
705 DISEASE PROGRESSION 951 0.0080
706 RENAL IMPAIRMENT 672 0.0080
707 HEPATOCELLULAR INJURY 113 0.0080
708 BLOOD BILIRUBIN INCREASED 215 0.0080
709 PSYCHOMOTOR HYPERACTIVITY 132 0.0079
710 RENAL INJURY 236 0.0079
711 ADVERSE EVENT 732 0.0079
712 FEELING ABNORMAL 1902 0.0079
713 HALLUCINATION, AUDITORY 126 0.0079
714 PRURITUS 3036 0.0079
715 DERMATITIS CONTACT 90 0.0079
716 ANKYLOSING SPONDYLITIS 104 0.0079
717 PHOTOPHOBIA 148 0.0079
718 HERNIA 152 0.0079
719 DEAFNESS 205 0.0078
720 NEOPLASM 90 0.0078
721 PERICARDIAL EFFUSION 181 0.0078
722 SEPTIC SHOCK 337 0.0077
723 HERPES ZOSTER 444 0.0077
724 CHOLECYSTITIS 92 0.0077
725 HYPERGLYCAEMIA 281 0.0077
726 CHOLESTASIS 148 0.0077
727 MICTURITION URGENCY 88 0.0077
728 DYSKINESIA 313 0.0077
729 MYOCARDIAL INFARCTION 1341 0.0077
730 DEVICE RELATED INFECTION 118 0.0077
731 PANCREATITIS 405 0.0077
732 PHARYNGITIS 95 0.0077
733 SCHIZOPHRENIA 93 0.0076
734 COLITIS 290 0.0076
735 HEADACHE 4788 0.0076
736 DYSPHAGIA 722 0.0076
737 DRUG PRESCRIBING ERROR 146 0.0076
738 WRONG TECHNIQUE IN DRUG USAGE PROCESS 276 0.0076
739 MUSCULOSKELETAL DISORDER 144 0.0076
740 MUCOSAL INFLAMMATION 198 0.0076
741 POISONING 95 0.0076
742 FEELING COLD 210 0.0075
743 BALANCE DISORDER 652 0.0075
744 BLOOD PRESSURE FLUCTUATION 181 0.0075
745 GASTROENTERITIS 110 0.0075
746 RHABDOMYOLYSIS 314 0.0075
747 HAEMOPTYSIS 210 0.0075
748 NEOPLASM MALIGNANT 502 0.0075
749 PERIPHERAL COLDNESS 103 0.0075
750 DRUG ERUPTION 132 0.0074
751 CHOLELITHIASIS 244 0.0074
752 WHITE BLOOD CELL COUNT DECREASED 804 0.0074
753 INITIAL INSOMNIA 76 0.0074
754 HAEMOGLOBIN DECREASED 758 0.0074
755 DECREASED ACTIVITY 79 0.0073
756 BLOOD URINE PRESENT 139 0.0073
757 GOUT 131 0.0073
758 LABORATORY TEST ABNORMAL 215 0.0073
759 DEPRESSED MOOD 384 0.0073
760 URINARY TRACT INFECTION 1238 0.0073
761 CARDIAC FAILURE CONGESTIVE 580 0.0072
762 DRUG INTERACTION 1144 0.0072
763 MULTIPLE FRACTURES 117 0.0071
764 OSTEONECROSIS 232 0.0071
765 COLON CANCER 105 0.0070
766 DIABETES MELLITUS 533 0.0070
767 KIDNEY INFECTION 137 0.0070
768 THYROID DISORDER 107 0.0069
769 ABASIA 171 0.0069
770 DIZZINESS 3439 0.0069
771 PNEUMONITIS 187 0.0069
772 LYMPHADENOPATHY 243 0.0069
773 CONVULSION 391 0.0068
774 HYPOKINESIA 99 0.0068
775 GAMMA-GLUTAMYLTRANSFERASE INCREASED 151 0.0068
776 DRY EYE 340 0.0068
777 VISUAL IMPAIRMENT 839 0.0068
778 PRODUCT USE ISSUE 1267 0.0067
779 BACTERIAL INFECTION 125 0.0067
780 TACHYPNOEA 91 0.0067
781 BLOOD PRESSURE INCREASED 1021 0.0067
782 MUSCLE TIGHTNESS 108 0.0067
783 COAGULOPATHY 111 0.0067
784 LUNG INFECTION 103 0.0066
785 DIALYSIS 94 0.0066
786 HAEMATOMA 171 0.0066
787 BLOOD PRESSURE DECREASED 438 0.0066
788 HYPOTENSION 1320 0.0066
789 ATAXIA 78 0.0066
790 FUNGAL INFECTION 219 0.0066
791 HAEMATURIA 225 0.0066
792 MOUTH ULCERATION 138 0.0065
793 DEMENTIA 183 0.0065
794 CEREBROVASCULAR ACCIDENT 1109 0.0065
795 LIVER FUNCTION TEST ABNORMAL 190 0.0065
796 HEART RATE INCREASED 647 0.0065
797 LUNG NEOPLASM MALIGNANT 268 0.0065
798 DIPLOPIA 169 0.0065
799 BLOOD CREATINE PHOSPHOKINASE INCREASED 186 0.0065
800 PROSTATIC SPECIFIC ANTIGEN INCREASED 89 0.0065
801 RASH PRURITIC 349 0.0064
802 CYSTITIS 205 0.0064
803 RASH MACULO-PAPULAR 143 0.0064
804 POLLAKIURIA 268 0.0064
805 CHOKING 125 0.0064
806 TRANSIENT ISCHAEMIC ATTACK 216 0.0064
807 CHROMATURIA 144 0.0064
808 PHARYNGEAL OEDEMA 98 0.0064
809 MULTI-ORGAN FAILURE 110 0.0064
810 FEMUR FRACTURE 196 0.0063
811 PHOTOSENSITIVITY REACTION 104 0.0063
812 FEELING HOT 386 0.0063
813 JAUNDICE 167 0.0062
814 HEART RATE IRREGULAR 140 0.0062
815 LOCAL SWELLING 108 0.0062
816 MOVEMENT DISORDER 198 0.0062
817 SINUS DISORDER 122 0.0062
818 GASTROENTERITIS VIRAL 111 0.0061
819 SWOLLEN TONGUE 192 0.0061
820 HAIR COLOUR CHANGES 76 0.0061
821 ARRHYTHMIA 289 0.0061
822 ORTHOSTATIC HYPOTENSION 106 0.0061
823 CARDIAC FAILURE 488 0.0061
824 PRODUCTIVE COUGH 290 0.0061
825 HOT FLUSH 457 0.0061
826 PRODUCT TASTE ABNORMAL 82 0.0060
827 ORAL DISCOMFORT 84 0.0060
828 SKIN FISSURES 118 0.0060
829 GINGIVAL BLEEDING 82 0.0060
830 SKIN DISORDER 200 0.0060
831 SINUS CONGESTION 81 0.0060
832 PALLOR 163 0.0060
833 BLOOD PRESSURE ABNORMAL 119 0.0060
834 LIMB DISCOMFORT 184 0.0059
835 SKIN DISCOLOURATION 273 0.0059
836 THIRST 106 0.0059
837 VERTIGO 361 0.0059
838 EPISTAXIS 442 0.0059
839 MANIA 97 0.0059
840 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 419 0.0059
841 UPPER GASTROINTESTINAL HAEMORRHAGE 98 0.0058
842 COLITIS ULCERATIVE 259 0.0058
843 PERITONITIS 120 0.0058
844 HAEMATOCHEZIA 319 0.0058
845 PELVIC PAIN 105 0.0058
846 DYSGEUSIA 428 0.0058
847 ATRIAL FIBRILLATION 561 0.0058
848 LEUKOPENIA 288 0.0058
849 EJECTION FRACTION DECREASED 89 0.0057
850 LACRIMATION INCREASED 173 0.0057
851 INTERNATIONAL NORMALISED RATIO INCREASED 163 0.0057
852 BLOOD COUNT ABNORMAL 86 0.0057
853 NODULE 74 0.0057
854 PRODUCT PHYSICAL ISSUE 113 0.0056
855 OROPHARYNGEAL PAIN 517 0.0056
856 THERAPEUTIC RESPONSE DECREASED 336 0.0055
857 INFLUENZA LIKE ILLNESS 456 0.0055
858 PANCREATITIS ACUTE 124 0.0055
859 PALPITATIONS 645 0.0055
860 GASTROINTESTINAL HAEMORRHAGE 460 0.0055
861 CLOSTRIDIUM DIFFICILE INFECTION 120 0.0055
862 BLINDNESS 224 0.0055
863 CEREBRAL INFARCTION 134 0.0055
864 SYNCOPE 547 0.0055
865 TREATMENT NONCOMPLIANCE 298 0.0054
866 HYPOACUSIS 233 0.0054
867 PRODUCT USE IN UNAPPROVED INDICATION 1336 0.0054
868 NEUTROPENIA 732 0.0054
869 DRUG INEFFECTIVE 7088 0.0054
870 MYALGIA 910 0.0053
871 THERAPEUTIC RESPONSE UNEXPECTED 238 0.0053
872 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 90 0.0053
873 EYE PAIN 299 0.0053
874 METABOLIC ACIDOSIS 169 0.0053
875 VISION BLURRED 723 0.0053
876 DYSPHONIA 307 0.0052
877 BURNING SENSATION 368 0.0052
878 ANGINA PECTORIS 149 0.0052
879 AGRANULOCYTOSIS 96 0.0052
880 ACUTE MYOCARDIAL INFARCTION 152 0.0051
881 FLATULENCE 292 0.0051
882 MELAENA 113 0.0051
883 RHINORRHOEA 330 0.0051
884 PROCEDURAL PAIN 141 0.0051
885 SHOCK 116 0.0050
886 BRAIN FOG 79 0.0050
887 ABNORMAL DREAMS 138 0.0050
888 BRADYCARDIA 265 0.0050
889 VENTRICULAR TACHYCARDIA 82 0.0050
890 CHEST DISCOMFORT 503 0.0049
891 RESPIRATORY TRACT CONGESTION 78 0.0049
892 HEMIPARESIS 83 0.0049
893 AGEUSIA 122 0.0049
894 PANCREATIC CARCINOMA 141 0.0049
895 RESPIRATORY TRACT INFECTION 127 0.0049
896 OFF LABEL USE 4246 0.0048
897 HYPOAESTHESIA ORAL 73 0.0048
898 PRODUCT QUALITY ISSUE 649 0.0048
899 DRUG DISPENSING ERROR 73 0.0048
900 DIABETES MELLITUS INADEQUATE CONTROL 84 0.0047
901 CYTOKINE RELEASE SYNDROME 95 0.0047
902 ELECTROCARDIOGRAM QT PROLONGED 170 0.0047
903 PRURITUS GENERALISED 102 0.0047
904 SWELLING FACE 307 0.0047
905 GLAUCOMA 90 0.0047
906 FACE OEDEMA 78 0.0046
907 FAECES DISCOLOURED 100 0.0046
908 RASH ERYTHEMATOUS 220 0.0046
909 GENERALISED TONIC-CLONIC SEIZURE 76 0.0046
910 CONJUNCTIVITIS 85 0.0046
911 CIRCULATORY COLLAPSE 78 0.0046
912 COUGH 1276 0.0045
913 DRUG LEVEL INCREASED 75 0.0045
914 DERMATITIS 94 0.0045
915 CEREBRAL HAEMORRHAGE 160 0.0045
916 HEAD DISCOMFORT 79 0.0045
917 NEUROTOXICITY 78 0.0044
918 VIRAL INFECTION 147 0.0044
919 INFLUENZA 490 0.0044
920 PRODUCT AVAILABILITY ISSUE 100 0.0044
921 EYE DISORDER 144 0.0044
922 PREMATURE BABY 131 0.0043
923 ABDOMINAL PAIN LOWER 110 0.0043
924 ECZEMA 226 0.0043
925 VISUAL ACUITY REDUCED 143 0.0043
926 PSORIASIS 558 0.0043
927 ORAL HERPES 83 0.0042
928 FLUSHING 430 0.0042
929 ERYTHEMA 869 0.0042
930 SKIN CANCER 91 0.0042
931 NASAL CONGESTION 248 0.0042
932 HYPOGLYCAEMIA 200 0.0041
933 MIDDLE INSOMNIA 77 0.0041
934 RASH GENERALISED 106 0.0041
935 PRESYNCOPE 99 0.0041
936 CATARACT 241 0.0040
937 SNEEZING 90 0.0040
938 PROTEINURIA 76 0.0040
939 PRODUCT SUBSTITUTION ISSUE 226 0.0039
940 LIP SWELLING 128 0.0038
941 HAEMORRHAGE 400 0.0038
942 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 267 0.0037
943 RASH MACULAR 127 0.0036
944 TRANSAMINASES INCREASED 80 0.0036
945 UNDERDOSE 262 0.0036
946 EYE SWELLING 131 0.0035
947 STEVENS-JOHNSON SYNDROME 78 0.0035
948 CARDIOVASCULAR DISORDER 89 0.0035
949 MULTIPLE SCLEROSIS 164 0.0034
950 HEPATOTOXICITY 75 0.0034
951 THROAT TIGHTNESS 91 0.0034
952 THROAT IRRITATION 148 0.0033
953 DIABETIC KETOACIDOSIS 77 0.0032
954 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 576 0.0032
955 ANAPHYLACTIC REACTION 172 0.0031
956 PRODUCT ADHESION ISSUE 111 0.0031
957 INCORRECT ROUTE OF DRUG ADMINISTRATION 111 0.0031
958 PRODUCT DOSE OMISSION 201 0.0031
959 ANAPHYLACTIC SHOCK 79 0.0031
960 BONE DENSITY DECREASED 95 0.0030
961 MULTIPLE SCLEROSIS RELAPSE 204 0.0030
962 DRUG DOSE OMISSION 489 0.0030
963 DRUG ADMINISTRATION ERROR 89 0.0029
964 DRY SKIN 385 0.0029
965 ABORTION SPONTANEOUS 114 0.0028
966 BLOOD GLUCOSE DECREASED 136 0.0028
967 COVID-19 493 0.0028
968 SKIN EXFOLIATION 237 0.0028
969 OCULAR HYPERAEMIA 131 0.0028
970 PRODUCT DOSE OMISSION ISSUE 804 0.0027
971 DISEASE RECURRENCE 126 0.0026
972 DRUG EFFECT INCOMPLETE 94 0.0026
973 BLOOD GLUCOSE INCREASED 464 0.0025
974 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 122 0.0022
975 EXTRA DOSE ADMINISTERED 88 0.0022
976 INCORRECT DOSE ADMINISTERED 490 0.0021
977 INJECTION SITE REACTION 144 0.0021
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 421 0.0021
979 THERAPY INTERRUPTED 148 0.0021
980 THERAPY CESSATION 104 0.0020
981 EYE IRRITATION 114 0.0020
982 ACNE 146 0.0019
983 BREAST CANCER 176 0.0019
984 INJECTION SITE BRUISING 148 0.0019
985 PROSTATE CANCER 143 0.0018
986 SKIN BURNING SENSATION 111 0.0015
987 INJECTION SITE PAIN 437 0.0014
988 INJECTION SITE PRURITUS 91 0.0014
989 DEVICE MALFUNCTION 88 0.0013
990 INJECTION SITE HAEMORRHAGE 98 0.0012
991 INJECTION SITE ERYTHEMA 151 0.0012
992 NO ADVERSE EVENT 188 0.0010
993 INJECTION SITE SWELLING 75 0.0010
994 DEVICE ISSUE 87 0.0010